MIRM(Mirum Pharmaceuticals, Inc.) 的财务报表:医疗保健,生物技术。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 科目 | FY 截至 2021-12-31 | FY 截至 2022-12-31 | FY 截至 2023-12-31 | FY 截至 2024-12-31 | FY 截至 2025-12-31 |
|---|---|---|---|---|---|
| 营业收入 | $19.14M | $77.06M | $186.37M | $336.89M | $521.31M |
| 毛利润 | — | — | — | — | — |
| 营业利润 | −$173.41M | −$131.22M | −$109.15M | −$87.61M | −$22.14M |
| 净利润 | −$83.99M | −$135.66M | −$163.41M | −$87.94M | −$23.36M |
| 经营现金流 | −$132.76M | −$120.14M | −$70.94M | $10.32M | $55.83M |
| 自由现金流 | −$132.78M | −$120.41M | −$71.05M | $9.33M | $54.87M |
| 摊薄每股收益 | $-2.77 | $-4.02 | $-4.00 | $-1.85 | $-0.47 |